THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
Qingyun LIU,Xing GONG,Kendra CARMON
申请号：
US16062386
公开号：
US20180369403A1
申请日:
2016.12.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Isolated or recombinant anti-LGR4 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.
